NDAINTRAVENOUSPOWDERPriority Review
Approved
Apr 2024
Lifecycle
Growth
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action Pegulicianine is a prodrug that is optically inactive when intact and produces a fluorescent signal after its peptide chain is cleaved by cathepsins and matrix metalloproteases (MMPs). The levels of these enzymes are higher in and around tumor and tumor-associated cells…
Indications (1)
Loss of Exclusivity
LOE Date
Sep 14, 2034
103 months away
Patent Expiry
Sep 14, 2034
Exclusivity Expiry
Apr 17, 2029
External Resources